No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
MeSH terms
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / therapeutic use
-
Disease Progression
-
Doxorubicin / adverse effects
-
Doxorubicin / therapeutic use
-
Etoposide / adverse effects
-
Etoposide / therapeutic use
-
Humans
-
Kaplan-Meier Estimate
-
Lymphoma, T-Cell, Peripheral / drug therapy*
-
Lymphoma, T-Cell, Peripheral / mortality
-
Lymphoma, T-Cell, Peripheral / pathology
-
Neoplasm Staging
-
Prednisone / adverse effects
-
Prednisone / therapeutic use
-
Rituximab / administration & dosage
-
Treatment Outcome
-
Vincristine / adverse effects
-
Vincristine / therapeutic use
Substances
-
Antibodies, Monoclonal, Humanized
-
Rituximab
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
siplizumab
-
Prednisone